• Home
  • About Us
  • Contact
  • Your Account
  • Subscribe
Thursday, June 30, 2022
  • Login
Alternatives Watch
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
No Result
View All Result
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
No Result
View All Result
Alternatives Watch
No Result
View All Result

Third Rock raises over $1bn for biotech potential

Susan BarretobySusan Barreto
June 16, 2022
in Manager News, Open Access, Private Equity
Third Rock raises over $1bn for biotech potential
ShareTweetShareSendSend

Third Rock Ventures closed the Third Rock Ventures Fund VI with $1.1 billion in commitments with the aim of building up biotech companies employing a hands-on approach with founders.

Fund VI is able to provide both initial Series A investment as well as follow-on capital to support companies throughout their lifecycle. Third Rock officials plan to allocate capital from Fund VI to invest in groundbreaking new companies from in the broader biotech ecosystem that are strongly aligned with Third Rock’s mission and strategy. The Boston-based firm will invest in approximately 10 biotech companies in the new fund.

“An important differentiator for Third Rock is the strength and maturity of our ideation ecosystem,” said Reid Huber, partner at Third Rock. “Our discovery pipeline is as robust as it has ever been, and with our established and proven model for integrating deep scientific and medical expertise with operational and business acumen, we are uniquely positioned to advance these innovations to patients.”

In addition to Huber, partners of Fund VI are Abbie Celniker, Neil Exter, Kevin Gillis, David Kaufman, M.D., Cary Pfeffer, M.D., Robert Tepper, M.D., and Jeffrey Tong. Third Rock also promoted Dodzie Sogah to venture partner. Dr. Sogah came to the firm in 2021 as an entrepreneur-in-residence, and now joins a team of business and scientific leaders in the venture partner role.

The $3.8 billion firm has invested in 60 companies. Importantly, companies across the portfolio have brought 18 products to the market across multiple therapeutic modalities and a broad range of disease indications including cancer, cardiovascular disease, depression, sickle cell disease, and rare genetic diseases among others.

“Over the course of our 15-year history, our focus on creating companies aimed at improving the lives of patients has not wavered,” said Gillis, partner and chief operating officer at Third Rock. “We have built a leading investor base that is supportive of our differentiated model that is hands on, team oriented, value creation driven, and built for the long term. We appreciate the strong support from existing limited partners and welcome our new investors.”

Tags: Life Sciences
ShareTweetShareSendSend
Previous Post

Two Sigma’s Venn names CEO

Next Post

MidOcean adds seasoned execs to private equity team

Related Posts

LACERA channels more money into alts
Pensions

LACERA channels more money into alts

D.E. Shaw reveals strategic financing from Harbert Infrastructure
Real Estate/Infrastructure

D.E. Shaw reveals strategic financing from Harbert Infrastructure

Kentucky Teachers hands out alts assignments
Pensions

Kentucky Teachers hands out alts assignments

Red Arts Capital finds value in the supply chain
Features

Red Arts Capital finds value in the supply chain

NM fund adds over $170 million to RE and PE
Pensions

NM fund adds over $170 million to RE and PE

Next Post
MidOcean adds seasoned execs to private equity team

MidOcean adds seasoned execs to private equity team

Log In

Lost your password?

Recent

LACERA channels more money into alts

LACERA channels more money into alts

D.E. Shaw reveals strategic financing from Harbert Infrastructure

D.E. Shaw reveals strategic financing from Harbert Infrastructure

Kentucky Teachers hands out alts assignments

Kentucky Teachers hands out alts assignments

Search the AW Archives

No Result
View All Result

Download

Alternatives Watch

© 2019-2022, All Rights Reserved  |  BMV Digital

Navigate Site

  • Hedge Funds
  • Private Equity
  • Private Credit
  • RE/Infrastructure
  • Investor News
  • Research

Follow Us

No Result
View All Result
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard

© 2019-2022, All Rights Reserved  |  BMV Digital

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Be an alts insider

Start your days in the know with our free newsletter

No, I don't want to be an alts insider

Thank

You!

Follow us
on LinkedIn

Cookie Consent
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie Settings Accept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
Save & Accept
Powered by CookieYes Logo